Fairmount Funds Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Buy
+3,220,368
New +$32.2M 4.17% 12